Ads
related to: acute lymphoma leukemia cancer- ALL Treatment Option
Component of Multi-Agent
Chemotherapy for ALL
- Dosing Schedule
Physicians, View Dosing Schedule
and Administration Info.
- About Treatment
Learn About a Potential
ALL Treatment Option.
- Ordering Guide
View HCP Resources and
Download Ordering Guide
- Patient Support
Learn More About
Patient Assistance Options.
- Clinical Data
View Safety &
Clinical Data Profile.
- ALL Treatment Option
Search results
Results from the WOW.Com Content Network
Deaths. 111,000 (2015) [10] Acute lymphoblastic leukemia ( ALL) is a cancer of the lymphoid line of blood cells characterized by the development of large numbers of immature lymphocytes. [1] Symptoms may include feeling tired, pale skin color, fever, easy bleeding or bruising, enlarged lymph nodes, or bone pain. [1]
T-cell acute lymphoblastic leukemia (T-ALL) is a type of acute lymphoblastic leukemia with aggressive malignant neoplasm of the bone marrow. Acute lymphoblastic leukemia (ALL) is a condition where immature white blood cells accumulate in the bone marrow, subsequently crowding out normal white blood cells and create build-up in the liver, spleen, and lymph nodes.
Specialty. Oncology, hematology. Adult T-cell leukemia/lymphoma ( ATL or ATLL) is a rare cancer of the immune system's T-cells [1] [2] [3] caused by human T cell leukemia/lymphotropic virus type 1 ( HTLV-1 ). [4] All ATL cells contain integrated HTLV-1 provirus further supporting that causal role of the virus in the cause of the neoplasm. [4]
Leukemia ( also spelled leukaemia and pronounced / luːˈkiːmiːə / [1] loo-KEE-mee-ə) is a group of blood cancers that usually begin in the bone marrow and result in high numbers of abnormal blood cells. [9] These blood cells are not fully developed and are called blasts or leukemia cells. [2]
The Leukemia & Lymphoma Society (LLS), a 501(c)(3) charitable organization founded in 1949, is a voluntary health organization dedicated to fighting blood cancer world-wide. LLS funds blood cancer research on cures for leukemia , lymphoma , Hodgkin's disease , and myeloma .
Acute lymphoblastic leukemia (ALL) 4.0% Acute myeloid leukemia (AML) 8.7% Chronic lymphocytic leukemia (CLL) sorted under lymphomas according to current WHO classification; called small lymphocytic lymphoma (SLL) when leukemic cells are absent. 10.2% Chronic myelogenous leukemia (CML) 3.7% Acute monocytic leukemia (AMoL) 0.7% Other leukemias 3.1%
Ads
related to: acute lymphoma leukemia cancer